drugset / Trial / NCT01017003

Pharmacokinetic Study With Colchicine in Healthy Volunteers

NCT01017003

Phase 1 Completed 14 enrolled Mutual Pharmaceutical Company, Inc.
Non-randomizedSingle-groupOpen-labelBasic science

Summary

This open label, single group, sequential dose study will compare the single dose pharmacokinetics of colchicine 0.6 mg given orally to colchicine pharmacokinetics after 10 days of a standard prophylactic dose (0.6 mg every 12 hours) in healthy volunteers.

Timeline

Start
2007-09
Primary completion
2007-10
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Colchicine Small molecule 0.6 mg

Indications

No indication recorded.